Ureshino, Hiroshi
Takahashi, Naoto http://orcid.org/0000-0002-6758-3787
Ikezoe, Takayuki
Kameoka, Yoshihiro
Kimura, Satoshi
Fukushima, Noriyasu
Ichinohe, Tatsuo
Takamori, Ayako
Kawaguchi, Atsushi
Miura, Masatomo
Kimura, Shinya
Funding for this research was provided by:
Pfizer Japan
Article History
Received: 20 April 2024
Revised: 17 July 2024
Accepted: 29 July 2024
First Online: 13 August 2024
Declarations
:
: NT declares personal fees from Novartis, Pfizer Inc., and Otsuka Pharmaceutical Co., Ltd. T. Ikezoe received honoraria from Pfizer, Otsuka Pharmaceuticals and Novartis, and research funding from Pfizer, Novartis and Otsuka Pharmaceuticals. T. Ichinohe received honoraria from Novaritis. Shinya Kimura received honoraria from Pfizer, Otsuka Pharmaceuticals, Novartis and Bristol-Myers-Squibb, and research funding from Pfizer, Bristol-Myers-Squibb and Ohara Pharmaceuticals. All other authors declare no competing interests.